Published 1 month ago

US takes next step in Medicare drug price negotiations with pharma companies

Summary by WTVB

WASHINGTON (Reuters) – The Biden administration said on Tuesday it has responded to offers from the manufacturers of 10 high-cost drugs selected for the U.S. Medicare program’s first-ever pricing negotiations, but provided no details. Part of 2022’s Inflation Reduction Act allows Medicare to negotiate prices for prescription drugs that had been particularly expensive for the federal health program that covers millions of Americans aged 65 an…

0 Articles

All

Left

Center

Right

Penn Live

Pharmacy Benefit Companies are advocates in fighting high drug prices

Recently, PennLive called on legislators to further regulate pharmacy benefit companies in an effort to lower prescription drug costs. Unfortunately, the editorial paints an inaccurate picture of the value that PBMs provide and endorses misguided proposals.The core mission of PBMs is to negotiate with drug companies to lower the cost of drugs and create affordable access for patients. Pharmacy benefit companies are proud of the work we do to sav…

1 month ago·Harrisburg, United States

Read Full Article